prostate cancer screenings

Bridging the gap between prostate radiology and pathology through machine learning

Prostate cancer remains the second deadliest cancer for men despite clinical advancements. Currently, Magnetic Resonance Imaging (MRI) is considered the most sensitive non-invasive imaging modality that enables visualisation, detection and localisation of prostate cancer, and is increasingly used to guide targeted biopsies for prostate cancer diagnosis. However, its utility remains limited due to high rates...

Read More


Metastatic prostate cancer cases surge following USPSTF-recommended slowdown in screenings

Source: Metastatic prostate cancer cases surged following the issuance of U.S. Preventive Services Task Force recommendations against routine screening for the disease, according to research published Monday. It was back in 2008 that the influential panel of experts urged against regular prostate-specific antigen testing among men older than 75, which spread to all ages by...

Read More

About Us

GCG Global Healthcare are specialists in healthcare excellence. Driven by a desire to improve healthcare and clinical solutions for everyone – patients, medical professionals and facilities. We aim to foster a culture of excellence through collaboration with industry experts and thought leaders to deliver better outcomes.